Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: May 3, 2024
Date Accepted: May 3, 2024

The final, peer-reviewed published version of this preprint can be found here:

Authors’ Response to Peer Reviews of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

Oyebola K, Ligali F, Owoloye A, Erinwusi B, Alo Y, Musa A, Aina O, Salako B

Authors’ Response to Peer Reviews of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

JMIRx Med 2024;5:e60174

DOI: 10.2196/60174

PMCID: 11441451

Author(s)’ Responses to Peer Review Reports

  • Kolapo Oyebola; 
  • Funmilayo Ligali; 
  • Afolabi Owoloye; 
  • Blessing Erinwusi; 
  • Yetunde Alo; 
  • Adesola Musa; 
  • Oluwagbemiga Aina; 
  • Babatunde Salako

ABSTRACT

his is the author(s)’ responses to peer review reports related to MS ID56993.


 Citation

Please cite as:

Oyebola K, Ligali F, Owoloye A, Erinwusi B, Alo Y, Musa A, Aina O, Salako B

Authors’ Response to Peer Reviews of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

JMIRx Med 2024;5:e60174

DOI: 10.2196/60174

PMCID: 11441451

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.